147 related articles for article (PubMed ID: 8905333)
1. Zaprinast, but not dipyridamole, reverses hemodynamic tolerance to nitroglycerin in vivo.
De Garavilla L; Pagani ED; Buchholz RA; Dundore R; Bode DC; Volberg ML; Jackson KN; Pratt P; Silver PJ
Eur J Pharmacol; 1996 Oct; 313(1-2):89-96. PubMed ID: 8905333
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.
Merkel LA; Rivera LM; Perrone MH; Lappe RW
Eur J Pharmacol; 1992 May; 216(1):29-35. PubMed ID: 1326438
[TBL] [Abstract][Full Text] [Related]
3. Reversal of nitroglycerin tolerance in vitro by the cGMP-phosphodiesterase inhibitor zaprinast.
Pagani ED; VanAller GS; O'Connor B; Silver PJ
Eur J Pharmacol; 1993 Oct; 243(2):141-7. PubMed ID: 8276063
[TBL] [Abstract][Full Text] [Related]
4. Lack of cross-tolerance between nitroglycerin and endothelium-derived relaxing factor-mediated vasoactive agents in spontaneously hypertensive rats.
De Garavilla L; Volberg ML; Pratt PF; Silver PJ; Buchholz RA
Eur J Pharmacol; 1993 Mar; 234(1):77-82. PubMed ID: 8386094
[TBL] [Abstract][Full Text] [Related]
5. Reversal or nitroglycerin tolerance by the cGMP phosphodiesterase inhibitor zaprinast.
Silver PJ; Pagani ED; de Garavilla L; Van Aller GS; Volberg ML; Pratt PF; Buchholz RA
Eur J Pharmacol; 1991 Jun; 199(1):141-2. PubMed ID: 1654265
[No Abstract] [Full Text] [Related]
6. N omega-nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast.
Dundore RL; Pratt PF; O'Connor B; Buchholz RA; Pagani ED
Eur J Pharmacol; 1991 Jul; 200(1):83-7. PubMed ID: 1663042
[TBL] [Abstract][Full Text] [Related]
7. Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats.
Dundore RL; Clas DM; Wheeler LT; Habeeb PG; Bode DC; Buchholz RA; Silver PJ; Pagani ED
Eur J Pharmacol; 1993 Nov; 249(3):293-7. PubMed ID: 8287916
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.
Harris AL; Lemp BM; Bentley RG; Perrone MH; Hamel LT; Silver PJ
J Pharmacol Exp Ther; 1989 May; 249(2):394-400. PubMed ID: 2566675
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells.
Papapetropoulos A; Go CY; Murad F; Catravas JD
Br J Pharmacol; 1996 Jan; 117(1):147-55. PubMed ID: 8825356
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5.
Silver PJ; Pagani ED; Dundore RL; de Garavilla L; Bode DC; Bacon ER
Eur J Pharmacol; 1998 May; 349(2-3):263-8. PubMed ID: 9671106
[TBL] [Abstract][Full Text] [Related]
11. Lack of cyclic nucleotide regulation of MBCQ-induced relaxation of rat ileal smooth muscle.
Kaneda T; Yamamoto H; Azegami Y; Shimizu K; Urakawa N; Nakajyo S
J Smooth Muscle Res; 2003 Jun; 39(3):47-54. PubMed ID: 14572172
[TBL] [Abstract][Full Text] [Related]
12. The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation.
Kruuse C; Rybalkin SD; Khurana TS; Jansen-Olesen I; Olesen J; Edvinsson L
Eur J Pharmacol; 2001 May; 420(1):55-65. PubMed ID: 11412839
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
Delpy E; le Monnier de Gouville AC
Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
[TBL] [Abstract][Full Text] [Related]
14. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
Silver PJ; Dundore RL; Bode DC; de Garavilla L; Buchholz RA; van Aller G; Hamel LT; Bacon E; Singh B; Lesher GY
J Pharmacol Exp Ther; 1994 Dec; 271(3):1143-9. PubMed ID: 7996419
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance.
Kim D; Rybalkin SD; Pi X; Wang Y; Zhang C; Munzel T; Beavo JA; Berk BC; Yan C
Circulation; 2001 Nov; 104(19):2338-43. PubMed ID: 11696475
[TBL] [Abstract][Full Text] [Related]
16. Relationship between cyclic guanosine monophosphate accumulation and relaxation of canine trachealis induced by nitrovasodilators.
Zhou HL; Torphy TJ
J Pharmacol Exp Ther; 1991 Sep; 258(3):972-8. PubMed ID: 1679854
[TBL] [Abstract][Full Text] [Related]
17. Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus.
Ziegler JW; Ivy DD; Fox JJ; Kinsella JP; Clarke WR; Abman SH
Am J Physiol; 1995 Aug; 269(2 Pt 2):H473-9. PubMed ID: 7653611
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of zaprinast on methacholine-induced contraction and inositol 1,4,5-trisphosphate accumulation in bovine tracheal smooth muscle.
Chilvers ER; Giembycz MA; Challiss RA; Barnes BJ; Nahorski SR
Br J Pharmacol; 1991 May; 103(1):1119-25. PubMed ID: 1652339
[TBL] [Abstract][Full Text] [Related]
19. Studies of vascular tolerance to nitroglycerin: effects of N-acetylcysteine, NG-monomethyl L-arginine, and endothelin-1.
Lawson DL; Haught WH; Mehta P; Mehta JL
J Cardiovasc Pharmacol; 1996 Sep; 28(3):418-24. PubMed ID: 8877589
[TBL] [Abstract][Full Text] [Related]
20. Role of nitric oxide and guanosine 3',5'-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries.
Liu SF; Crawley DE; Rohde JA; Evans TW; Barnes PJ
Br J Pharmacol; 1992 Nov; 107(3):861-6. PubMed ID: 1335345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]